Market News
Sarepta Faces FDA Scrutiny Over Elevidys Safety Concerns
Sarepta’s Elevidys faces FDA scrutiny after patient deaths spark safety concerns. Will the gene therapy stay on the market? Click...
21/07/2025
1 views